1. Home
  2. SRCE vs NKTR Comparison

SRCE vs NKTR Comparison

Compare SRCE & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 1st Source Corporation

SRCE

1st Source Corporation

HOLD

Current Price

$90.09

Market Cap

2.1B

Sector

Finance

ML Signal

HOLD

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$72.17

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRCE
NKTR
Founded
1863
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.2B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
SRCE
NKTR
Price
$90.09
$72.17
Analyst Decision
Hold
Strong Buy
Analyst Count
4
7
Target Price
$74.50
$146.67
AVG Volume (30 Days)
119.4K
725.0K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
2.37%
N/A
EPS Growth
19.59
N/A
EPS
3.58
N/A
Revenue
N/A
$307,711,000.00
Revenue This Year
$10.29
N/A
Revenue Next Year
$3.16
N/A
P/E Ratio
$25.37
N/A
Revenue Growth
N/A
86.00
52 Week Low
$56.89
$21.60
52 Week High
$91.46
$109.00

Technical Indicators

Market Signals
Indicator
SRCE
NKTR
Relative Strength Index (RSI) 74.15 58.40
Support Level $65.26 $64.28
Resistance Level $91.46 $76.32
Average True Range (ATR) 1.81 3.21
MACD 0.36 0.21
Stochastic Oscillator 88.89 82.98

Price Performance

Historical Comparison
SRCE
NKTR

About SRCE 1st Source Corporation

1st Source Corp provides specialized financing services for construction equipment, aircraft, and vehicle types through its Specialty Finance activities. The company offers commercial, small business, agricultural, and real estate loans, along with commercial leasing, treasury management, and payment services, including Fedwires, ACH, and merchant services. It also provides Renewable Energy Financing for commercial solar projects, a full range of consumer banking products, Trust and Wealth Advisory Services, and insurance products. The company operates in the commercial banking segment, which provides commercial and consumer banking services, trust and wealth advisory services, and insurance to individual and business clients across its markets.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: